Impact of SARS‐CoV‐2 infection on risk of prematurity, birthweight and obstetric complications: A multivariate analysis from a nationwide, population‐based retrospective cohort study
“… [1] , [2] , [3] , [4] , [5] , [6] , [7] , [8] , [9] People with a SARS-CoV-2 infection during pregnancy also have worse maternal outcomes than those that do not. [6] , [10] , [11] , [12] , [13] , [14] , [15] , [16] SARS-CoV-2 infection and related complications has also disproportionately impacted minority populations and people with lower socioeconomic status. [11] , [16] , [17] , [18] , [19] In addition, SARS-CoV-2 variants have had significantly different impacts on COVID-19 severity in pregnant people.…”
Section: Maternal Sars-cov-2 Infection Impact On Maternal-fetal Outcomesmentioning
confidence: 99%
“…In addition, people with COVID-19 during pregnancy universally had more severe outcomes than those that did not. [6] , [10] , [11] , [12] , [13] , [14] , [15] , [16] Pregnant people that had a COVID-19 during pregnancy have a 2.7-4.6 fold increased risk for a thrombotic event compared to pregnant people that did not have an infection ( Table 2 ). [11] , [16] They also had a 1.7-13.5 fold increased rate of ICU admission [6] , [10] , [11] , [12] , [13] , [14] , [15] , [16] and a 2.8-25.4 fold increased risk of mechanical ventilation ( Table 2 ).…”
Section: Maternal Sars-cov-2 Infection Impact On Maternal-fetal Outcomesmentioning
“… [1] , [2] , [3] , [4] , [5] , [6] , [7] , [8] , [9] People with a SARS-CoV-2 infection during pregnancy also have worse maternal outcomes than those that do not. [6] , [10] , [11] , [12] , [13] , [14] , [15] , [16] SARS-CoV-2 infection and related complications has also disproportionately impacted minority populations and people with lower socioeconomic status. [11] , [16] , [17] , [18] , [19] In addition, SARS-CoV-2 variants have had significantly different impacts on COVID-19 severity in pregnant people.…”
Section: Maternal Sars-cov-2 Infection Impact On Maternal-fetal Outcomesmentioning
confidence: 99%
“…In addition, people with COVID-19 during pregnancy universally had more severe outcomes than those that did not. [6] , [10] , [11] , [12] , [13] , [14] , [15] , [16] Pregnant people that had a COVID-19 during pregnancy have a 2.7-4.6 fold increased risk for a thrombotic event compared to pregnant people that did not have an infection ( Table 2 ). [11] , [16] They also had a 1.7-13.5 fold increased rate of ICU admission [6] , [10] , [11] , [12] , [13] , [14] , [15] , [16] and a 2.8-25.4 fold increased risk of mechanical ventilation ( Table 2 ).…”
Section: Maternal Sars-cov-2 Infection Impact On Maternal-fetal Outcomesmentioning
“… 27 Previous studies report a reduced transplacental transfer of IgG in placental pathologies, prematurity, low-birth-weight infants, and male fetuses 28 , 29 , 30 , 31 and suggest SARS-CoV-2 infection may be a risk factor for prematurity. 32 Specific to SARS-CoV-2, transplacental transfer occurs at a higher efficiency when infection is more than 2 months before delivery but decreases if infection occurs in the third trimester. 33 , 34 , 35 The timing of COVID-19 infection during pregnancy and the duration of transplacental immunity may be useful to explain differences in SARS CoV-2 antibody reactivity with gestational age.…”
IMPORTANCESerosurveys can be used to monitor population-level dynamics of COVID-19 and vaccination. Dried blood spots (DBSs) collected from infants contain maternal IgG antibodies and are useful for serosurveys of individuals recently giving birth. OBJECTIVES To examine SARS-CoV-2 antibody prevalence in pregnant individuals in New York State, identify associations between SARS-CoV-2 antibody status and maternal and infant characteristics, and detect COVID-19 vaccination among this population. DESIGN, SETTING, AND PARTICIPANTS A population-based, repeated cross-sectional study was conducted to detect SARS-CoV-2 nucleocapsid (N) and spike (S) IgG antibodies. Deidentified DBS
“…É importante enfatizar que a presença de comorbidades como a diabetes, obesidade e coinfecção bacteriana são relacionados a eventos adversos da gestação, como o trabalho de parto prematuro (SIMON et al, 2022). Notou-se uma proporção de SARS-CoV-2 em amostras placentárias, sendo que a ECA2 é fortemente expressa na interface materno-fetal envolvendo a placenta e decídua, logo supõe que o vírus pode invadir e danificar a placenta, aumentando assim sua permeabilidade placentária, provavelmente levando uma insuficiência placentária e complicações obstétricas, como o parto prematuro (JAFARI et al, 2021).…”
Section: Discussionunclassified
“…;( CHI, J. et al, 2021);(KARASEK et al, 2021) e (SIMON et al, 2022. Os partos prematuros de causas iatrogênicas foram evidenciados em 20% 2/10 (BLOISE et al, 2021) e(TURAN et al, 2020).…”
Em 11 de fevereiro de 2020 a Organização Mundial de Saúde (OMS) denominou uma nova doença, Coronavírus 19 (COVID-19) e sendo declarada a pandemia em março de 2021. A COVID-19 é causada por Coronavírus 2 de Síndrome Respiratória Aguda Grave (SARS- CoV-2). Gestantes foram suscetíveis a desenvolver um quadro clínico mais grave. A COVID-19 se relaciona a desfechos maternos e fetais adversos, incluindo admissão na Unidade de Terapia Intensiva (UTI), cesariana, sofrimento fetal e parto prematuro. Esta revisão integrativa teve como objetivo identificar os fatores que contribuem para que gestantes com COVID-19 evoluam para parto prematuro. Foram seguidos os critérios propostos pelo Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), a partir de publicações cientificas encontradas nas bases de dados Science Direct, PubMed e Biblioteca Virtual em Saúde (BVS/MEDLINE), direcionada com o auxílio dos descritores “preterm birth”, “premature birth labor”, “pregnancy” e “coronavirus infection”, verificados no Descritores em Ciências da Saúde. Foram eleitos os seguintes critérios de inclusão: responder à pergunta principal, artigos publicados entre os anos de 2019 e 2021 e nos idiomas inglês e português. Como resultados o estudo contou com uma amostra de 10 artigos que preencheram os critérios de inclusão, sendo que os estudos deveriam apresentar fatores de risco que influenciassem a progressão do parto prematuro em gestantes infectadas por COVID-19. Conclui-se, portanto, que um conjunto de fatores podem desencadear o parto prematuro, como a infecção por SARS-CoV-2 no terceiro trimestre da gestação, comorbidades, a coinfecção bacteriana, hipoxemia placentária, coagulopatias, transtornos mentais e iatrogênia. No entanto, é necessário estudos com uma população maior para homogeneizar os resultados.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.